← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Scintillon Institute For Photobiology
San Diego, CA
$28,292,386
Total funding
32
Grants
Funding over time
peak $6.6M · FY2014–25$10M$7.5M$5M$2.5M$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$28,292,386 · 32
By mechanism
R01$16,774,631 · 12
R35$2,479,765 · 1
P01$2,278,805 · 5
R21$2,038,410 · 5
DP1$1,663,864 · 1
R61$1,025,015 · 1
Investigators at Scintillon Institute For Photobiology
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
Cellular/Molecular Pathophysiology of Intellectual and Developmental Disabilities$1,387,295
P01 · FY2016 · HD
Intersection of Neuro-Immune-Vascular Dynamics in Preclinical NeuroHIV Model$1,025,015
R61 · FY2025 · NS
Novel Proteomics Approach to HIV-Associated Neurocognitive Disorder & Drug Abuse$945,000
DP1 · FY2016 · DA
La Jolla Interdisciplinary Neuroscience Center Cores$900,299
P30 · FY2016 · NS
Cellular/Molecular Pathophysiology of Intellectual and Developmental Disabilities$891,510
P01 · FY2015 · HD
Cerebellar-striatal circuits for control of dopamine activity and food intake$710,797
R01 · FY2024 · DK
Cerebellar-striatal circuits for control of dopamine activity and food intake$681,297
R01 · FY2025 · DK
Raman Flow Cytometry for Diagnostics and Drug Delivery$663,399
R01 · FY2014 · EB
Novel Proteomics Approach to HIV-Associated Neurocognitive Disorder & Drug Abuse$623,469
DP1 · FY2017 · DA
Defining the functional organization of cerebellar output circuits that control feeding behavior$579,227
R01 · FY2021 · DK
Defining the functional organization of cerebellar output circuits that control feeding behavior$568,735
R01 · FY2023 · DK
Defining the functional organization of cerebellar output circuits that control feeding behavior$557,897
R01 · FY2022 · DK
Defining the functional organization of cerebellar output circuits that control feeding behavior$542,778
R01 · FY2024 · DK
Repurposing an FDA approved Drug, B-Raf Kinase Inhibitor Dabrafenib for Protection from Cisplatin- and Noise- induced Hearing Loss$533,267
R01 · FY2024 · DC
Repurposing an FDA approved Drug, B-Raf Kinase Inhibitor Dabrafenib for Protection from Cisplatin- and Noise- induced Hearing Loss$533,267
R01 · FY2025 · DC
Testing energy expenditures as biomarkers of aging using thermal imaging in a controlled environment$529,650
R21 · FY2024 · AG
NAD(P)H quinone oxidoreductase 1 (NQO1)-mediated bypass of mitochondrial electron transport chain with artificial and endogenous substrates$529,650
R21 · FY2023 · AG
Testing the utility of miBioAge as a personalized aging biomarker$509,750
R21 · FY2024 · AG
CAR T CELLS ENGINEERED TO KILL HIV-INFECTED CELLS WHILE SECRETING BROADLY NEUTRALIZING ANTIBODIES$480,000
R01 · FY2023 · AI
CAR T CELLS ENGINEERED TO KILL HIV-INFECTED CELLS WHILE SECRETING BROADLY NEUTRALIZING ANTIBODIES$480,000
R01 · FY2022 · AI